(19)
(11) EP 4 739 322 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24740869.3

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
A61K 35/15(2025.01)
A61K 35/17(2025.01)
C12N 5/00(2006.01)
 A61K 35/16(2015.01)
A61P 35/00(2006.01)
A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/15; A61K 35/17; A61K 35/16; A61P 35/00; A61K 2300/00; A61K 40/19; A61K 40/4254; A61K 40/11
 
C-Sets:
  1. A61K 2300/00, A61K 35/17;
  2. A61K 2300/00, A61K 35/15;
  3. A61K 2300/00, A61K 35/16;
(86) International application number:
PCT/EP2024/069136
(87) International publication number:
WO 2025/008546 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 05.07.2023 EP 23183719

(71) Applicant: R.G.C.C. Holdings AG
6300 Zug (CH)

(72) Inventor:
  • PAPASOTIRIOU, Ioannis
    6315 Oberägeri (CH)

(74) Representative: Pestalozzi, Deborah 
Isler & Pedrazzini AG Postfach 1772
8027 Zürich
8027 Zürich (CH)

   


(54) PHARMACEUTICAL PRODUCT FOR AUTOLOGOUS ADOPTIVE CELLULAR THERAPY